189 related articles for article (PubMed ID: 7840587)
1. Safety of famciclovir in patients with herpes zoster and genital herpes.
Saltzman R; Jurewicz R; Boon R
Antimicrob Agents Chemother; 1994 Oct; 38(10):2454-7. PubMed ID: 7840587
[TBL] [Abstract][Full Text] [Related]
2. Famciclovir: review of clinical efficacy and safety.
Cirelli R; Herne K; McCrary M; Lee P; Tyring SK
Antiviral Res; 1996 Mar; 29(2-3):141-51. PubMed ID: 8739594
[TBL] [Abstract][Full Text] [Related]
3. Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes.
Simpson D; Lyseng-Williamson KA
Drugs; 2006; 66(18):2397-416. PubMed ID: 17181386
[TBL] [Abstract][Full Text] [Related]
4. Oral famciclovir for the suppression of recurrent genital herpes: a randomized controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
Diaz-Mitoma F; Sibbald RG; Shafran SD; Boon R; Saltzman RL
JAMA; 1998 Sep; 280(10):887-92. PubMed ID: 9739972
[TBL] [Abstract][Full Text] [Related]
5. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group.
Mertz GJ; Loveless MO; Levin MJ; Kraus SJ; Fowler SL; Goade D; Tyring SK
Arch Intern Med; 1997 Feb; 157(3):343-9. PubMed ID: 9040303
[TBL] [Abstract][Full Text] [Related]
6. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group.
Tyring S; Barbarash RA; Nahlik JE; Cunningham A; Marley J; Heng M; Jones T; Rea T; Boon R; Saltzman R
Ann Intern Med; 1995 Jul; 123(2):89-96. PubMed ID: 7778840
[TBL] [Abstract][Full Text] [Related]
7. One-day famciclovir vs. placebo in patient-initiated episodic treatment of recurrent genital herpes in immunocompetent Black patients.
Leone P; Abudalu M; Mitha E; Gani M; Zhou W; Hamed K
Curr Med Res Opin; 2010 Mar; 26(3):653-61. PubMed ID: 20070143
[TBL] [Abstract][Full Text] [Related]
8. Clinic-initiated, twice-daily oral famciclovir for treatment of recurrent genital herpes: a randomized, double-blind, controlled trial.
Sacks SL; Aoki FY; Martel AY; Shafran SD; Lassonde M
Clin Infect Dis; 2005 Oct; 41(8):1097-104. PubMed ID: 16163627
[TBL] [Abstract][Full Text] [Related]
9. Famciclovir. A review of its pharmacological properties and therapeutic efficacy in herpesvirus infections.
Perry CM; Wagstaff AJ
Drugs; 1995 Aug; 50(2):396-415. PubMed ID: 8521764
[TBL] [Abstract][Full Text] [Related]
10. Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials.
Tyring SK; Diaz-Mitoma F; Shafran SD; Locke LA; Sacks SL; Young CL
J Cutan Med Surg; 2003; 7(6):449-54. PubMed ID: 15931690
[TBL] [Abstract][Full Text] [Related]
11. Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes. A randomized, double-blind multicenter trial. Canadian Famciclovir Study Group.
Sacks SL; Aoki FY; Diaz-Mitoma F; Sellors J; Shafran SD
JAMA; 1996 Jul; 276(1):44-9. PubMed ID: 8667538
[TBL] [Abstract][Full Text] [Related]
12. Single-day, patient-initiated famciclovir therapy versus 3-day valacyclovir regimen for recurrent genital herpes: a randomized, double-blind, comparative trial.
Abudalu M; Tyring S; Koltun W; Bodsworth N; Hamed K
Clin Infect Dis; 2008 Sep; 47(5):651-8. PubMed ID: 18637755
[TBL] [Abstract][Full Text] [Related]
13. Double-blind, randomized, acyclovir-controlled, parallel-group trial comparing the safety and efficacy of famciclovir and acyclovir in patients with uncomplicated herpes zoster.
Shen MC; Lin HH; Lee SS; Chen YS; Chiang PC; Liu YC
J Microbiol Immunol Infect; 2004 Apr; 37(2):75-81. PubMed ID: 15181487
[TBL] [Abstract][Full Text] [Related]
14. Single-day, patient-initiated famciclovir therapy for recurrent genital herpes: a randomized, double-blind, placebo-controlled trial.
Aoki FY; Tyring S; Diaz-Mitoma F; Gross G; Gao J; Hamed K
Clin Infect Dis; 2006 Jan; 42(1):8-13. PubMed ID: 16323085
[TBL] [Abstract][Full Text] [Related]
15. Advances in the treatment of herpesvirus infection: the role of famciclovir.
Tyring SK
Clin Ther; 1998; 20(4):661-70. PubMed ID: 9737826
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of famciclovir and valacyclovir for suppression of recurrent genital herpes and viral shedding.
Wald A; Selke S; Warren T; Aoki FY; Sacks S; Diaz-Mitoma F; Corey L
Sex Transm Dis; 2006 Sep; 33(9):529-33. PubMed ID: 16540883
[TBL] [Abstract][Full Text] [Related]
17. Famiciclovir therapy (famvir) for herpes simplex and herpes zoster infections.
Tyring S
Skin Therapy Lett; 2001 Nov; 6(12):1-2, 5. PubMed ID: 11753535
[TBL] [Abstract][Full Text] [Related]
18. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial.
Chosidow O; Drouault Y; Leconte-Veyriac F; Aymard M; Ortonne JP; Pouget F; Revuz J; Decazes JM; Malkin JE
Br J Dermatol; 2001 Apr; 144(4):818-24. PubMed ID: 11298543
[TBL] [Abstract][Full Text] [Related]
19. A randomized, double-blind trial of famciclovir versus acyclovir for the treatment of localized dermatomal herpes zoster in immunocompromised patients.
Tyring S; Belanger R; Bezwoda W; Ljungman P; Boon R; Saltzman RL;
Cancer Invest; 2001; 19(1):13-22. PubMed ID: 11291551
[TBL] [Abstract][Full Text] [Related]
20. Once, twice, or three times daily famciclovir compared with aciclovir for the oral treatment of herpes zoster in immunocompetent adults: a randomized, multicenter, double-blind clinical trial.
Shafran SD; Tyring SK; Ashton R; Decroix J; Forszpaniak C; Wade A; Paulet C; Candaele D
J Clin Virol; 2004 Apr; 29(4):248-53. PubMed ID: 15018852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
